The Author's Reply to "Performance of Donor-Derived Cell-Free DNA Assays in Kidney Transplant Patients"
- PMID: 32317616
- DOI: 10.1097/TP.0000000000003085
The Author's Reply to "Performance of Donor-Derived Cell-Free DNA Assays in Kidney Transplant Patients"
Comment on
-
Analytical Validation of a Single-nucleotide Polymorphism-based Donor-derived Cell-free DNA Assay for Detecting Rejection in Kidney Transplant Patients.Transplantation. 2019 Dec;103(12):2657-2665. doi: 10.1097/TP.0000000000002665. Transplantation. 2019. PMID: 30801536 Free PMC article.
-
Performance of Donor-derived Cell-free DNA Assays in Kidney Transplant Patients.Transplantation. 2020 May;104(5):e135. doi: 10.1097/TP.0000000000003084. Transplantation. 2020. PMID: 32044893 No abstract available.
References
-
- Altuğ Y, Liang N, Ram R, et al. Analytical validation of a single-nucleotide polymorphism-based donor-derived cell-free DNA assay for detecting rejection in kidney transplant patients.Transplantation20191032657–2665
-
- Sigdel TK, Archila FA, Constantin T, et al. Optimizing detection of kidney transplant injury by assessment of donor-derived cell-free DNA via massively multiplex PCR.J Clin Med201881E19
-
- Grskovic M, Hiller DJ, Eubank LA, et al. Validation of a clinical-grade assay to measure donor-derived cell-free DNA in solid organ transplant recipients.J Mol Diagn2016186890–902
-
- Bloom RD, Bromberg JS, Poggio ED, et al.; Circulating Donor-Derived Cell-Free DNA in Blood for Diagnosing Active Rejection in Kidney Transplant Recipients (DART) Study InvestigatorsCell-free DNA and active rejection in kidney allografts.J Am Soc Nephrol20172872221–2232
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
